A randomized prospective study comparing concomitant chemoradiotherapy using paclitaxel-carboplatin with concomitant chemoradiotherapy using etoposide-cisplatin in inoperable or nonresectable locally advanced non-small cell lung cancer
Clinical Cancer Investigation Journal · 2020 · 9 (2) · 27
DOI: 10.4103/ccij.ccij_94_19 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cancer Investigation Journal, 2020. Verfasst von GY Srinivasa und 5 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Context
Several randomized trials have established that the best survival can be achieved in patients with locally advanced non-small cell lung cancer (NSCLC) with concurrent chemoradiation (CRT). In this study, we have compared different chemotherapy regime along with radiation in locally advanced NSCLC.
Aims
Compare the disease response, toxicity, quality of life (QoL) and overall survival in concomitant CRT using paclitaxel-carboplatin versus cisplatin-etoposide for the radical treatment of
Zitieren
APA
Srinivasa, G., Gupta, M., Seam, R., Rana, S., Verma, S., & Gupta, M. (2020). A randomized prospective study comparing concomitant chemoradiotherapy using paclitaxel-carboplatin with concomitant chemoradiotherapy using etoposide-cisplatin in inoperable or nonresectable locally advanced non-small cell lung cancer. Clinical Cancer Investigation Journal, 9(2), 27. https://doi.org/10.4103/ccij.ccij_94_19
Vancouver
Srinivasa G, Gupta M, Seam R, Rana S, Verma S, Gupta M. A randomized prospective study comparing concomitant chemoradiotherapy using paclitaxel-carboplatin with concomitant chemoradiotherapy using etoposide-cisplatin in inoperable or nonresectable locally advanced non-small cell lung cancer. Clinical Cancer Investigation Journal. 2020;9(2):27. doi:10.4103/ccij.ccij_94_19
BibTeX
@article{Srinivasa2020,
author = {Srinivasa, GY and Gupta, Manish and Seam, RajeevK and Rana, Sakshi and Verma, Shalini and Gupta, Manoj},
title = {A randomized prospective study comparing concomitant chemoradiotherapy using paclitaxel-carboplatin with concomitant chemoradiotherapy using etoposide-cisplatin in inoperable or nonresectable locally advanced non-small cell lung cancer},
journal = {Clinical Cancer Investigation Journal},
year = {2020},
volume = {9},
number = {2},
pages = {27},
doi = {10.4103/ccij.ccij_94_19}
}
EUVIMED